Stifel Financial Corp Mesoblast LTD Transaction History

Stifel Financial Corp

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.87 - $7.85 $509,938 - $681,945	-86,872 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$6.69 - $9.0 $176,154 - $236,979	26,331 Added 43.49%	86,872 $650,000
Q1 2021 May 14, 2021	BUY	$8.26 - $11.4 $5,013 - $6,919	607 Added 1.01%	60,541 $501,000
Q4 2020 Feb 12, 2021	BUY	$8.21 - $18.59 $52,133 - $118,046	6,350 Added 11.85%	59,934 $509,000
Q3 2020 Nov 16, 2020	BUY	$11.33 - $19.81 $21,946 - $38,371	1,937 Added 3.75%	53,584 $996,000
Q2 2020 Aug 14, 2020	BUY	$4.2 - $15.45 $21,382 - $78,655	5,091 Added 10.94%	51,647 $588,000
Q1 2020 May 14, 2020	SELL	$3.38 - $10.63 $67 - $212	-20 Reduced 0.04%	46,556 $204,000
Q4 2019 Feb 13, 2020	SELL	$5.74 - $7.42 $3,903 - $5,045	-680 Reduced 1.44%	46,576 $343,000
Q3 2019 Nov 13, 2019	BUY	$4.68 - $7.42 $4,946 - $7,842	1,057 Added 2.29%	47,256 $329,000
Q2 2019 Aug 14, 2019	SELL	$4.67 - $5.88 $36,262 - $45,658	-7,765 Reduced 14.39%	46,199 $244,000
Q1 2019 May 14, 2019	BUY	$4.19 - $5.25 $4,210 - $5,276	1,005 Added 1.9%	53,964 $279,000
Q4 2018 Feb 13, 2019	SELL	$3.51 - $8.6 $18,160 - $44,496	-5,174 Reduced 8.9%	52,959 $218,000
Q3 2018 Nov 13, 2018	BUY	$5.75 - $8.16 $209,294 - $297,015	36,399 Added 167.47%	58,133 $476,000
Q2 2018 Aug 14, 2018	BUY	$5.27 - $6.21 $5,053 - $5,955	959 Added 4.62%	21,734 $119,000
Q1 2018 May 11, 2018	BUY	$4.91 - $7.72 $1,306 - $2,053	266 Added 1.3%	20,775 $118,000
Q4 2017 Feb 14, 2018	BUY	$4.91 - $7.23 $33,417 - $49,207	6,806 Added 49.67%	20,509 $118,000
Q3 2017 Nov 13, 2017	BUY	$5.4 - $7.41 $73,996 - $101,539	13,703	13,703 $0

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.